Telemedicine and lower-barrier access to buprenorphine hold potential to make gains against the opioid epidemic after the COVID-19 crisis subsides.
Substance Use Disorder
Isolation and barriers to harm reduction services could increase overdoses and new HIV infections among people who use drugs, experts worry.
Addiction expert Miriam Komaromy, MD offers a frank look at the opioid epidemic and shares how efforts are underway to keep crucial care accessible.
Experts call for integrated subspecialty training that acknowledges the relationship between addiction and infectious disease.
Boston Public Health Commission’s Devin Larkin explains that how services are delivered matters for engagement and retention in treatment for substance use disorder.